Simulations Plus to Be Acquired by Affiliates of Altaris in $375M All-Cash Deal

Simulations Plus has entered a definitive agreement to be purchased by affiliates of Altaris in an all-cash transaction valued at approximately $375m.

Under the deal, Simulations Plus shareholders will receive $18.50 per share, representing a 26% premium to the 60-day volume-weighted average price as of 15 June 2026.

Read more at Pharmaceutical Technology